This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study, Einstein (São Paulo), January 2022, Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein,
DOI: 10.31744/einstein_journal/2022ao0149.
You can read the full text:
The following have contributed to this page
